跳至主要内容
临床试验/IRCT20200722048166N1
IRCT20200722048166N1已完成未知

Comparing the effect of preprocedural loading dose of Arorvastatin vs Rrosuvastatin on prevalence of no-reflow and low TIMI flow in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention

Tabriz University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • All patients who are candidates primary percutaneous intervention with acute myocardial infarction with ST-segment elevation are admitted to the emergency department of Madani heart center of Tabriz.

排除标准

  • The patients with chronic disease such as inflammatory diseases, renal failure, a history of collagen and vascular disease, current active infection, blood diseases.
  • The patients with history of acute myocardial infarction or ischemic heart disease.
  • The patients with history of diabetes.

研究者

相似试验

Atorvastatin and Rosuvastatin in myocardial infarctio | 临床试验